Breast Cancer 1 (BRCA1) (pSer1457) antibody

Details for Product No. ABIN151685
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

 
Antigen
Synonyms BRCA1
Epitope
pSer1457
(41), (35), (24), (18), (16), (15), (14), (14), (13), (12), (10), (8), (6), (4), (4), (3), (3), (2), (2), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Reactivity
Human
(336), (44), (23), (13), (2), (1), (1), (1)
Host
Rabbit
(295), (62), (3), (1)
Clonality
Polyclonal
Conjugate
Un-conjugated
(14), (13), (11), (9), (9), (9), (9), (9), (9), (9), (9), (3), (3), (3)
Application
Immunoprecipitation (IP), Western Blotting (WB)
(194), (92), (90), (86), (68), (66), (50), (5), (5), (1), (1), (1)
Pubmed 1 reference available
Catalog no. ABIN151685
Quantity 0.1 mg
Price
Contact our Customer Service for availability and price in your country.
Shipping to United States (Change)
Add to Basket

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Immunogen for this antibody was a phosphorylated synthetic peptide, whichrepresented a portion of human Breast Cancer Gene 1 (GeneID 672) around serine1457 according to the numbering given in entry NP_009225.1.
Specificity ABIN151685 reacts with BRCA1Phosphorylated:Ser1457. Species Reactivity: Human.
Cross-Reactivity Human
Purification Aff - Purified
Alternative Name BRCA1 / RNF53
Background BRCA 1 contains at least two nuclear localization signals and is proposed to be a tumorsuppressor protein. It is a serine phosphoprotein that undergoes hyperphosphorylationduring late G1 and S phases of the cell cycle and is transiently dephosphorylated earlyafter M phase. BRCA 1 protein alters in a qualitative and quantitative manner during cellcycle progression. The amount of BRCA protein is highest during S phase and remainselevated toward G2 / M, before it declines in early G1 phase. Inherited loss of BRCA 1function confers an increased susceptibility for both breast and ovarian cancer. Alternate Names: anti-Breast Cancer 1 antibody, anti-Breast cancer 1 early onset antibody, anti-Breastcancer type 1 susceptibility protein antibody, anti-Breast Ovarian Cancer Susceptibilityantibody, anti-Papillary serous carcinoma of the peritoneum antibody, anti-PSCPantibody, anti-RNF53 antibody.
Gene ID 672
NCBI Accession NP_0092251
Application Notes Suggested working dilutions: immunoprecipitation 2.5 ug/mg lysate,Western Blot 1:1,000 to 1:10,000
Restrictions For Research Use only
Buffer Tris-citrate/phosphate buffer, pH 7 to 8. Preservative: 0.09% Sodium Azide.
Preservative Sodium azide
Storage 4 °C
Supplier Images
anti-Breast Cancer 1 (BRCA1) (pSer1457) antibody anti-Breast Cancer 1 (BRCA1) (pSer1457) antibody
General Bekker-Jensen, Lukas, Kitagawa et al.: "Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks." in: The Journal of cell biology, Vol. 173, Issue 2, pp. 195-206, 2006 (PubMed).

Hosts (295), (62), (3), (1)
Reactivities (336), (44), (23), (13), (2), (1), (1), (1)
Applications (194), (92), (90), (86), (68), (66), (50), (5), (5), (1), (1), (1)
Conjugates (14), (13), (11), (9), (9), (9), (9), (9), (9), (9), (9), (3), (3), (3)
Epitopes (41), (35), (24), (18), (16), (15), (14), (14), (13), (12), (10), (8), (6), (4), (4), (3), (3), (2), (2), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
back to top